OviTex® PRS P20263-1020GRecalls & reported problems
Tela Bio, Inc. · The OviTex® PRS Reinforced Tissue Matrix Device is a sterile reinforced matrix device comprised of non-dermal sourced layers of extracellular matrix (ECM) (ovine (sheep) derived ECM), paired with a minimal suture footprint. The OviTex PRS Reinforced Tissue Matrix Device provides an alternative device solution to permanent synthetic, resorbable/bioabsorbable synthetic, and biologic meshes. The device is permeable to facilitate fluid management, provides controlled stretch, and will incorporate into recipient tissue with associated cellular and microvascular ingrowth. Reinforced tissue matrices remodel into host tissue while maintaining compatibility with the body. The OviTex PRS Reinforced Tissue Matrix Device is for use in plastic and reconstructive surgery. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 7
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00810055070770), received between May 16, 2024 and Jul 25, 2025 — classified as 7 injuries.
The most frequently reported specific device problem is “Material Disintegration” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem5
- Material Disintegration2
Patient problems
- Fluid Discharge6
- Seroma1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.
Patient problems: Fluid Discharge
MAUDE report 22609630 ↗InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.
Patient problems: Fluid Discharge
MAUDE report 22609557 ↗InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.
Patient problems: Fluid Discharge
MAUDE report 22609555 ↗InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.
Patient problems: Fluid Discharge
MAUDE report 22609554 ↗InjuryFeb 26, 2025Material Disintegration; Material Disintegration
A PATIENT UNDERWENT BILATERAL MASTOPEXY WITH REVISION AUGMENTATION (BREAST IMPLANTS WERE APPROXIMATELY 20 YEARS OLD) ON (B)(6)2024. A PARTIAL CAPSULECTOMY WAS PERFORMED ANTERIORLY WITH MENTOR BOOST 480CC IMPLANTS AND OVITEX PRS LTR. ON (B)(6)2025 IT WAS NOTED THAT THE LEFT INCISION OPENED WITH OVITEX PRS PARTIALLY RESORBED WITH SOME POLYMER REMAINING. THE BREAST IMPLANT WAS REMOVED WITH THE NON-REMODELED OVITEX PRS. A SIMILAR EVENT OCCURRED AT THE RIGHT INCISION ON (B)(6)2025. PARTIAL OVITEX PRS INTEGRATION WAS NOTED ON BOTH SIDES.
Patient problems: Fluid Discharge
MAUDE report 21472954 ↗InjuryFeb 26, 2025Material Disintegration; Material Disintegration
A PATIENT UNDERWENT BILATERAL PRIMARY MASTOPEXY AUGMENTATION ON APPROXIMATELY (B)(6) 2024 WITH OVITEX PRS LTR USED AS LOWER POLE SUPPORT. THE PATIENT'S COURSE WAS UNREMARKABLE UNTIL 5 WEEKS POST-OP WHEN INCISIONS BROKE DOWN WITH IMPLANT EXPOSED. IT WAS NOTED THAT THE DEVICE WAS MOSTLY INCORPORATED SUPERIORLY BUT HAD RESORBED INFERIORLY. NON-INCORPORATED PORTIONS WERE REMOVED ALONG WITH THE BREAST IMPLANTS. THE PATIENT WAS LEFT TO HEAL PRIOR TO FINAL BREAST IMPLANT PLACEMENT.
Patient problems: Fluid Discharge
MAUDE report 21472837 ↗InjuryMay 16, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PATIENT UNDERWENT BILATERAL PREPECTORAL TWO STAGE BREAST RECONSTRUCTION WITH TISSUE EXPANDERS AND OVITEX PRS. WITHIN APPROXIMATELY TWO WEEKS, ONE SIDE DEVELOPED A SEROMA. ON THE CONTRALATERAL SIDE DRAINAGE WAS NOTED THROUGH THE SURGICAL WOUND. THE SURGEON REMOVED BOTH TISSUE EXPANDERS AND OVITEX PRS DEVICES.
Patient problems: Seroma
MAUDE report 19330854 ↗
Other Mesh, Surgical devices
- MEDPOR TITAN 81032Stryker Leibinger GmbH & Co. KG · Mesh, surgical1 recall1 report
- Peri-Guard PC1016NSynovis Life Technologies, Inc. · Mesh, surgical1 recall1 report
- SurgiMend® 606-200-020Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-005-001Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-300-008Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-200-016Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-300-021Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
- SurgiMend® 606-206-007Tei Biosciences Inc. · Mesh, surgical1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page